143 related articles for article (PubMed ID: 7600636)
21. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.
de Boer JP; Creasy AA; Chang A; Roem D; Brouwer MC; Eerenberg AJ; Hack CE; Taylor FB
Circ Shock; 1993 Jan; 39(1):59-67. PubMed ID: 7683256
[TBL] [Abstract][Full Text] [Related]
22. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
Kaiser B; Fareed J
Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
[TBL] [Abstract][Full Text] [Related]
23. Vasopressin release during sepsis and septic shock in baboons and dogs.
Wilson MF; Brackett DJ; Hinshaw LB; Tompkins P; Archer LT; Benjamin BA
Surg Gynecol Obstet; 1981 Dec; 153(6):869-72. PubMed ID: 7029759
[TBL] [Abstract][Full Text] [Related]
24. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock.
Wilson MF; Brackett DJ; Tompkins P; Benjamin B; Archer LT; Hinshaw LB
Adv Shock Res; 1981; 6():15-26. PubMed ID: 6760706
[TBL] [Abstract][Full Text] [Related]
25. Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis.
Camerota AJ; Creasey AA; Patla V; Larkin VA; Fink MP
J Infect Dis; 1998 Mar; 177(3):668-76. PubMed ID: 9498446
[TBL] [Abstract][Full Text] [Related]
26. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
Lupu C; Kruithof EK; Kakkar VV; Lupu F
Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651
[TBL] [Abstract][Full Text] [Related]
27. Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model.
Harper PL; Taylor FB; DeLa Cadena RA; Courtney M; Colman RW; Carrell RW
Thromb Haemost; 1998 Nov; 80(5):816-21. PubMed ID: 9843177
[TBL] [Abstract][Full Text] [Related]
28. Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment.
Hinshaw LB; Coalson JJ; Benjamin BA; Archer LT; Beller BK; Kling OR; Hasser EM; Phillips RW
Surg Gynecol Obstet; 1978 Oct; 147(4):545-57. PubMed ID: 100890
[TBL] [Abstract][Full Text] [Related]
29. The inflammatory-coagulant axis in the host response to gram-negative sepsis: regulatory roles of proteins and inhibitors of tissue factor.
Taylor FB
New Horiz; 1994 Nov; 2(4):555-65. PubMed ID: 7804804
[TBL] [Abstract][Full Text] [Related]
30. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
Hinshaw LB; Tekamp-Olson P; Chang AC; Lee PA; Taylor FB; Murray CK; Peer GT; Emerson TE; Passey RB; Kuo GC
Circ Shock; 1990 Mar; 30(3):279-92. PubMed ID: 2178801
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.
Lupu C; Westmuckett AD; Peer G; Ivanciu L; Zhu H; Taylor FB; Lupu F
Am J Pathol; 2005 Oct; 167(4):1161-72. PubMed ID: 16192650
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
[TBL] [Abstract][Full Text] [Related]
33. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
34. [Generation of recombinant human tissue factor pathway inhibitor in E. coli].
Leng X; Wang C; Song L; Li X; Ma J; Wang P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):314-7. PubMed ID: 12856608
[TBL] [Abstract][Full Text] [Related]
35. Arachidonic acid cascade metabolites in porcine E. coli shock. Coagulation, fibrinolytic and hemodynamic response.
Svartholm E; Bergqvist D; Hedner U; Ljungberg J; Haglund U
Acta Chir Scand; 1988 Feb; 154(2):133-9. PubMed ID: 2451368
[TBL] [Abstract][Full Text] [Related]
36. Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits.
Palmier MO; Hall LJ; Reisch CM; Baldwin MK; Wilson AG; Wun TC
Thromb Haemost; 1992 Jul; 68(1):33-6. PubMed ID: 1514170
[TBL] [Abstract][Full Text] [Related]
37. Glutamine induces heat-shock protein and protects against Escherichia coli lipopolysaccharide-induced vascular hyporeactivity in rats.
Jing L; Wu Q; Wang F
Crit Care; 2007; 11(2):R34. PubMed ID: 17346354
[TBL] [Abstract][Full Text] [Related]
38. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.
Taylor FB; Chang A; Ruf W; Morrissey JH; Hinshaw L; Catlett R; Blick K; Edgington TS
Circ Shock; 1991 Mar; 33(3):127-34. PubMed ID: 2044206
[TBL] [Abstract][Full Text] [Related]
39. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
